UNRESECTABLE ENDOMETRIAL CARCINOMA
Clinical trials for UNRESECTABLE ENDOMETRIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE ENDOMETRIAL CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Custom-Made cancer vaccine shows promise in advanced tumors
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, combined with the immunotherapy drug pembrolizumab, for people with advanced solid tumors (like breast, lung, or skin cancer). The goal is to see if the combination is safe and helps the immune syst…
Matched conditions: UNRESECTABLE ENDOMETRIAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New triple therapy aims to shrink Hard-to-Treat endometrial tumors
Disease control Recruiting nowThis early-phase study tests whether combining two cancer drugs (lenvatinib and pembrolizumab) with a short course of pelvic radiation is safe and effective for people with recurrent or inoperable endometrial cancer. About 18 participants will receive the treatment to find the be…
Matched conditions: UNRESECTABLE ENDOMETRIAL CARCINOMA
Phase: PHASE1 • Sponsor: Aaron Wolfson • Aim: Disease control
Last updated May 22, 2026 14:03 UTC